Baloush-Kleinman Vered, Poyurovsky Michael, Koren Dany, Schneidman Michael, Weizman Abraham, Shnitt Dan
School of Social-Work, Tel-Aviv University.
Harefuah. 2002 Dec;141(12):1042-9, 1090.
Antipsychotic agents are the mainstay of treatment for schizophrenia. However, almost 50% of schizophrenia patients exhibit non-compliance with antipsychotic drug therapy. This in turn may account for high relapse rate, reduced quality of life and increased burden on society. Identification of factors that may mediate adherence to treatment is therefore a primary clinical challenge. This paper reviews the literature regarding medication adherence among schizophrenia patients, with an emphasis on four groups of mediating factors: illness-related, patient-related, treatment-related and environmental-related factors. In addition, we describe a modified health-belief model that may facilitate better understanding of empirical findings. Therapeutic interventions to encourage better treatment compliance are discussed.
抗精神病药物是治疗精神分裂症的主要手段。然而,近50%的精神分裂症患者不依从抗精神病药物治疗。这反过来可能导致高复发率、生活质量下降以及社会负担加重。因此,识别可能影响治疗依从性的因素是一项主要的临床挑战。本文回顾了关于精神分裂症患者药物依从性的文献,重点关注四类中介因素:疾病相关因素、患者相关因素、治疗相关因素和环境相关因素。此外,我们描述了一种改良的健康信念模型,该模型可能有助于更好地理解实证研究结果。文中还讨论了鼓励提高治疗依从性的治疗干预措施。